BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16164939)

  • 1. Laparoscopic-assisted axillary dissection in breast cancer surgery.
    Lim SM; Lam FL
    Am J Surg; 2005 Oct; 190(4):641-3. PubMed ID: 16164939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic-assisted subcutaneous mastectomy and axillary dissection with immediate mammary prosthesis reconstruction for early breast cancer.
    Ho WS; Ying SY; Chan AC
    Surg Endosc; 2002 Feb; 16(2):302-6. PubMed ID: 11967683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less is more: transmammary axillary lymph node evaluation: an initial clinical experience.
    Cocilovo C; Boolbol SK; Valdes E; Feldman S
    Am J Surg; 2006 Oct; 192(4):478-80. PubMed ID: 16978953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary Dissection with Access Minimized (ADAM): a new technique for lymph node dissection in conservative surgery for breast cancer.
    Paepke S; Schwarz-Boeger U; Kiechle M; Jacobs VR
    Int J Fertil Womens Med; 2003; 48(5):232-7. PubMed ID: 14626380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
    Spillane AJ; Brennan ME
    Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
    Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
    Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary staging in women with small invasive breast tumours.
    della Rovere GQ; Bonomi R; Ashley S; Benson JR
    Eur J Surg Oncol; 2006 Sep; 32(7):733-7. PubMed ID: 16814511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of axillary level I and II lymphnode dissection on the therapy of stage I and II breast cancer.
    Tocchi A; Mazzoni G; Bettelli E; Miccini M; Giuliani A; Cassini D
    Panminerva Med; 2001 Jun; 43(2):103-7. PubMed ID: 11449180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of early breast cancer in day surgery.
    Marrazzo A; Taormina P; David M; Riili I; Lo Gerfo D; Casà L; Noto A; Mercadante S
    Chir Ital; 2007; 59(5):687-91. PubMed ID: 18019641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
    Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
    Davit FE; Gatmaitan P; Garguilo G
    Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial comparing level II and level III axillary node dissection in addition to mastectomy for breast cancer.
    Tominaga T; Takashima S; Danno M
    Br J Surg; 2004 Jan; 91(1):38-43. PubMed ID: 14716791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast-conserving surgery in breast cancer].
    Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
    G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of locoregional and axillary recurrences among patients following breast cancer operations.
    Bakos I; Almássy S
    Acta Chir Hung; 1997; 36(1-4):9-10. PubMed ID: 9408268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.